3 duped Malayali women return home from Saudi after Embassy intervention

December 11, 2016

Dammam, Dec 11: Three Malayali women, who were cheated by a travel agent in Kerala, returned home after the intervention of Indian embassy.fraud

According to them, an Ernakulam-based agency had recruited 21 Malayali women for a Riyadh-based contracting company engaged in cleaning work of government hospitals.While signing the contract in Kerala, the agency had offered them SR1,500 as monthly salary and collected Rs 85,000 to Rs 1.5 lakh from them as fees. The women reached Riyadh on March 1, 2016.

On reaching the Kingdom they were asked to sign a document in Arabic. They realized the double-dealing when they got first month's salary of SR 800 against the promised SR 1,500. When complained they were told that the job contract they had signed in Kerala was not valid and their salary and other terms depend on the agreement in Arabic. As per the Saudi labor law, job contracts prepared abroad should not be amended.

Apart from Arabic, the agreement should be in foreign worker's mother tongue and as well as in English. In this case, norms are violated.

The Malayali women contacted the company and diplomatic mission through a community activist. They were reluctant to work at SR 800 as salary and expressed desire to return home but the company refused to release them.However, the Indian embassy pressurized the company to issue exit visas to the Malayali women.

The company agreed to give exit visa to 11 women from Kerala. First batch of three have already left and eight others will leave shortly. Navodaya Kudumba Vedi, the women wing of Navodaya gave air tickets to these women. The rest of the women will remain with the company till the expiry of the contract.

Comments

A. Mangalore
 - 
Sunday, 11 Dec 2016

Well done. Now trace that B....d travel agent and teach him a lesson.

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
coastaldigest.com web desk
July 1,2020

The United States of America has bought almost the entire world's supply of remdesivir, one of just two drugs proven to treat COVID-19. 

“President Trump has struck an amazing deal to ensure Americans have access to the first authorised therapeutic for Covid-19,” said the US health and human services secretary, Alex Azar. 

“To the extent possible, we want to ensure that any American patient who needs remdesivir can get it. The Trump administration is doing everything in our power to learn more about life-saving therapeutics for Covid-19 and secure access to these options for the American people.”

The announcement implies that no other country in the world will be able to buy remdesivir for next three months at least.

The anti-viral drug patented by the US-based Gilead biotech firm is the only one approved by the European Medicines Agency (EMA) to treat patients with the novel coronavirus.

The Trump administration has already shown that it is prepared to outbid and outmanoeuvre all other countries to secure the medical supplies it needs for the US.

“They’ve got access to most of the drug supply [of remdesivir], so there’s nothing for Europe,” said Dr Andrew Hill, senior visiting research fellow at Liverpool University.

Remdesivir, the first drug approved by licensing authorities in the US to treat Covid-19, is made by Gilead and has been shown to help people recover faster from the disease. 

The first 140,000 doses, supplied to drug trials around the world, have been used up. The Trump administration has now bought more than 500,000 doses, which is all of Gilead’s production for July and 90% of August and September.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
June 29,2020

Mangaluru, Jun 29: A hospital set up in 1848 in the Port City has to remain closed till July 5 as majority of the Doctors and Staff at Lady Goschen Government Hospital are quarantined after coming in contact with a COVID-19 infected person.

Hospital Medical Superintendent said that both in-patient and out-patient wings of the hospital will remain closed till July 5 as there is a need to fumigate and sanitise all the departments of the hospital. Patients for treatment under 'Ayushman Bharat – Arogya Karnataka' scheme will be sent to private medical colleges with the referral card from the hospital. The hospital will start functioning normally from July 6.

The Lady Goschen Government Hospital, earlier known as the maternity Hospital, is the oldest hospital in the district and dates back to 1848.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.
News Network
March 14,2020

Kalaburagi, Mar 14: Utter negligence of Kalaburagi health department officials was one of the main reasons for the death of his father, alleged family member of Kalaburagi man and India's first COVID-19 victim here on Friday.

The victim's son said 'if officials of Kalaburagi health department had advised us to admit his father in isolated ward, which was opened in Gulbarga Institute of Medical science (GIMS), my father's survival time may have been extended,' he said.

Comments

Add new comment

  • Coastaldigest.com reserves the right to delete or block any comments.
  • Coastaldigset.com is not responsible for its readers’ comments.
  • Comments that are abusive, incendiary or irrelevant are strictly prohibited.
  • Please use a genuine email ID and provide your name to avoid reject.